InVivo Therapeutics Holdings - 9 Year Stock Price History | NVIV

Historical daily share price chart and data for InVivo Therapeutics Holdings since 2010 adjusted for splits. The latest closing stock price for InVivo Therapeutics Holdings as of May 22, 2019 is 1.08.
  • The all-time high InVivo Therapeutics Holdings stock price is 567.00, which is 52400% above the current share price.
  • The InVivo Therapeutics Holdings 52-week high stock price is 7.40, which is 585.2% above the current share price.
  • The InVivo Therapeutics Holdings 52-week low stock price is 1.08, which is 0% below the current share price.
  • The average InVivo Therapeutics Holdings stock price for the last 52 weeks is 2.08.
InVivo Therapeutics Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 1.4883 1.6300 1.7100 1.0800 1.0800 -28.48%
2018 6.4742 22.7500 22.7500 1.4000 1.5100 -92.16%
2017 62.9060 103.7500 123.7500 19.0000 19.2500 -81.67%
2016 146.4831 181.7500 246.2500 91.5000 105.0000 -41.67%
2015 270.6587 130.0000 444.5000 130.0000 180.0000 36.36%
2014 134.3373 224.0000 260.0000 50.0000 132.0000 -42.61%
2013 263.1389 175.0000 567.0000 110.0000 230.0000 32.18%
2012 212.9680 279.0000 284.0000 128.0000 174.0000 -36.73%
2011 120.9246 196.0000 310.0000 60.0000 275.0000 22.22%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.011B $0.000B
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.131B 26.04
Medtronic (MDT) Ireland $117.713B 17.21
Stryker (SYK) United States $69.192B 24.69
Boston Scientific (BSX) United States $52.428B 25.13
Baxter (BAX) United States $38.416B 24.21
Zimmer Biomet Holdings (ZBH) United States $23.779B 15.28
Smith & Nephew SNATS (SNN) United Kingdom $18.325B 0.00
ResMed (RMD) United States $16.130B 30.82
Canopy Growth (CGC) Canada $15.483B 0.00
Aurora Cannabis (ACB) Canada $8.782B 86.60
Bio-Rad Laboratories (BIO) United States $8.771B 46.50
Perrigo (PRGO) Ireland $6.771B 11.45
Hill-Rom Holdings (HRC) United States $6.428B 19.49
Insulet (PODD) United States $6.250B 455.39
GW Pharmaceuticals (GWPH) United Kingdom $5.550B 0.00
Haemonetics (HAE) United States $5.160B 42.33
ICU Medical (ICUI) United States $4.655B 27.78
Hutchison China MediTech (HCM) China $3.566B 0.00
NuVasive (NUVA) United States $3.229B 26.37
Neogen (NEOG) United States $3.055B 49.67
Agios Pharmaceuticals (AGIO) United States $3.015B 0.00
Quidel (QDEL) United States $2.225B 23.09
National Vision Holdings (EYE) United States $2.148B 45.77
Aphria (APHA) $1.712B 0.00
HEXO (HEXO) $1.478B 0.00
Cardiovascular Systems (CSII) United States $1.382B 793.40
Phibro Animal Health (PAHC) United States $1.185B 17.76
AtriCure (ATRC) United States $1.153B 0.00
VAREX IMAGING (VREX) United States $1.091B 23.15
Lantheus Holdings (LNTH) United States $0.960B 25.50
NanoString Technologies (NSTG) United States $0.945B 0.00
Omeros (OMER) United States $0.931B 0.00
MacroGenics (MGNX) United States $0.915B 0.00
PetIQ (PETQ) United States $0.834B 20.25
Eagle Pharmaceuticals (EGRX) United States $0.773B 21.69
Cerus (CERS) United States $0.733B 0.00
TG Therapeutics (TGTX) United States $0.616B 0.00
Surmodics (SRDX) United States $0.528B 76.71
OraSure Technologies (OSUR) United States $0.526B 24.20
LeMaitre Vascular (LMAT) United States $0.523B 25.33
Quanterix (QTRX) United States $0.513B 0.00
Meridian Bioscience (VIVO) United States $0.480B 14.68
Evolus (EOLS) United States $0.479B 0.00
BioLife Solutions (BLFS) United States $0.346B 108.18
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.304B 21.06
Vapotherm (VAPO) United States $0.284B 0.00
Rockwell Medical (RMTI) United States $0.280B 0.00
Zynex (ZYXI) United States $0.255B 26.37
Owens & Minor (OMI) United States $0.232B 4.91
Cytosorbents (CTSO) United States $0.224B 0.00
Bovie Medical (APYX) United States $0.201B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Fonar (FONR) United States $0.134B 7.07
Chembio Diagnostics (CEMI) United States $0.129B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
Female Health (VERU) United States $0.105B 0.00
InfuSystems Holdings (INFU) United States $0.095B 0.00
United-Guardian (UG) United States $0.094B 20.71
Neurotrope (NTRP) United States $0.093B 0.00
Insys Therapeutics (INSY) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 20.25
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.028B 0.00
BRAINSWAY LTD (BWAY) Israel $0.027B 0.00
Valeritas Holdings (VLRX) United States $0.020B 0.00
Myomo (MYO) United States $0.017B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 4.57